Hybrid muco-adhesive delivery systems and use thereof

Havazelet H·比安科皮里德; Avi A·施罗德; Shlomit S·阿维丹什洛莫维奇; Yarden Y·德格尼; Mor M·哥德费得

Hybrid muco-adhesive delivery systems and use thereof

Havazelet H·比安科皮里德 (Inventor), Avi A·施罗德 (Inventor), Shlomit S·阿维丹什洛莫维奇 (Inventor), Yarden Y·德格尼 (Inventor), Mor M·哥德费得 (Inventor)

Chemical Engineering

Research output: Patent

Abstract

A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a hybrid system, composed of polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents, is provided.

Original language	American English
Patent number	CN109562060
IPC	A61K 47/ 36 A I
Priority date	21/06/17
State	Published - 2 Apr 2019

Cite this

@misc{de6eeed6001f4deea38639e2e4a38fa1,

title = "Hybrid muco-adhesive delivery systems and use thereof",

abstract = "A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a hybrid system, composed of polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents, is provided.",

author = "Havazelet H·比安科皮里德 and Avi A·施罗德 and Shlomit S·阿维丹什洛莫维奇 and Yarden Y·德格尼 and Mor M·哥德费得",

year = "2019",

month = apr,

day = "2",

language = "American English",

type = "Patent",

note = "CN109562060; A61K 47/ 36 A I",

}

TY - PAT

T1 - Hybrid muco-adhesive delivery systems and use thereof

AU - H·比安科皮里德, Havazelet

AU - A·施罗德, Avi

AU - S·阿维丹什洛莫维奇, Shlomit

AU - Y·德格尼, Yarden

AU - M·哥德费得, Mor

PY - 2019/4/2

Y1 - 2019/4/2

N2 - A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a hybrid system, composed of polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents, is provided.

AB - A composition and method for the administration of therapeutic and/or diagnostic agents is provided. Specifically, a hybrid system, composed of polymer that harbors drug-loaded lipid nanoparticles, and use thereof for the administration of active agents e.g., anti-cancer agents, is provided.

M3 - Patent

M1 - CN109562060

ER -

Hybrid muco-adhesive delivery systems and use thereof

Abstract

Fingerprint

Cite this